Improved oral bioavailability of glyburide by a self-nanoemulsifying drug delivery system

Journal of Microencapsulation

Volumn 31, Issue 3, 2014, Pages 277-283

  Liu, Hongzhuo ^a   Shang, Kuimao ^a   Liu, Weina ^a   Leng, Donglei ^a   Li, Ran ^a   Kong, Ying ^a   Zhang, Tianhong ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Bioavailability; Glyburide; in vitro release; Self nanoemulsifying drug delivery system

Indexed keywords

COSURFACTANT; CREMOPHOR; GLIBENCLAMIDE; MIGLYOL; OIL; PROPYLENE GLYCOL; ANTIDIABETIC AGENT; EMULSION; NANOPARTICLE;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DOG; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG ELIMINATION; DRUG FORMULATION; DRUG HALF LIFE; DRUG RELEASE; DRUG SOLUBILITY; DRUG STABILITY; ELECTRIC CONDUCTIVITY; IN VITRO STUDY; MAXIMUM PLASMA CONCENTRATION; NANOEMULSION; NONHUMAN; PARTICLE SIZE; PLASMA CONCENTRATION-TIME CURVE; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; TIME TO MAXIMUM PLASMA CONCENTRATION; ZETA POTENTIAL; ANIMAL; BIOAVAILABILITY; CHEMISTRY; DRUG SCREENING; EMULSION; ORAL DRUG ADMINISTRATION;

ADMINISTRATION, ORAL; ANIMALS; BIOLOGICAL AVAILABILITY; DOGS; DRUG DELIVERY SYSTEMS; DRUG EVALUATION, PRECLINICAL; EMULSIONS; GLYBURIDE; HYPOGLYCEMIC AGENTS; NANOPARTICLES;

EID: 84909986008     PISSN: 02652048     EISSN: 14645246     Source Type: Journal    
DOI: 10.3109/02652048.2013.843598     Document Type: Article

References (27)

1. Aburuz S, Millership J, Mcelnay J. The development and validation of liquid chromatography method for the simultaneous determination of metformin and glipizide, gliclazide, glibenclamide or glimperide in plasma. J Chromatogr B Analyt Technol Biomed Life Sci, 2005;817: 277-86.
2. Bachhav YG, Patravale VB. SMEDDS of glyburide: formulation, in vitro evaluation, and stability studies. AAPS PharmSciTech, 2009;10:482-7.
3. Carlson RF, Isley WL, Ogrinc FG, Klobucar TR. Efficacy and safety of reformulated, micronized glyburide tablets in patients with noninsulin- dependent diabetes mellitus: A multicenter, double-blind, randomized trial. Clin Ther, 1993;15:788-96.
4. Cirri M RM, Maestrelli F, Mura P, Valleri M. Development of glyburide fast-dissolving tablets based on the combined use of cyclodextrins and polymers. Drug Dev Ind Pharm, 2009;35:73-82.
5. Date AA, Desai N, Dixit R, Nagarsenker M. Self-nanoemulsifying drug delivery systems: Formulation insights, applications and advances. Nanomedicine (Lond), 2010;5:1595-616.
6. Fatouros DG, Karpf DM, Nielsen FS, Mullertz A. Clinical studies with oral lipid based formulations of poorly soluble compounds. Ther Clin Risk Manag, 2007;3:591-604.
7. Gedeon C, Behravan J, Koren G, Piquette-miller M. Transport of glyburide by placental ABC transporters: Implications in fetal drug exposure. Placenta, 2006;27:1096-102.
8. Goole J, Lindley DJ, Roth W, Carl SM, Amighi K, Kauffmann J-M, Knipp GT. The effects of excipients on transporter mediated absorption. Int J Pharmaceut, 2010;393:17-31.
9. Gursoy RN, Benita S. Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs. Biomed Pharmacother, 2004;58:173-82.
10. Kassem AA, Marzouk MA, Ammar AA, Elosaily GH. Preparation and in vitro evaluation of self-nanoemulsifying drug delivery systems (SNEDDS) containing clotrimazole. Drug Discov Ther, 2010;4:373-9.
11. Klein S, Wempe MF, Zoeller T, Buchanan NL, Lambert JL, Ramsey MG, Edgar KJ, Buchanan CM. Improving glyburide solubility and dissolution by complexation with hydroxybutenyl-beta-cyclodextrin. J Pharm Pharmacol, 2009;61:23-30.
12. Kohli K, Chopra S, Dhar D, Arora S, Khar RK. Self-emulsifying drug delivery systems: an approach to enhance oral bioavailability. Drug Discov Today, 2010;15:958-65.
13. Larsen AT, Ohlsson AG, Polentarutti B, Barker RA, Phillips AR, Abu-rmaileh R, Dickinson PA, Abrahamsson B, Ostergaard J, Mullertz A. Oral bioavailability of cinnarizine in dogs: Relation to SNEDDS droplet size, drug solubility and in vitro precipitation. Eur J Pharm Sci 2013;48:339-50.
14. Liu YZP, Feng N, Zhang X, Wu S, Zhao J. Optimization and in situ intestinal absorption of self-microemulsifying drug delivery system of oridonin. Int J Pharm, 2009;365:136-42.
15. Mahmoud EA, Bendas ER, Mohamed MI. Preparation and evaluation of self-nanoemulsifying tablets of carvedilol. AAPS PharmSciTech, 2009; 10:183-92.
16. Mura P, Valleri M, Cirri M, Mennini N. New solid self-microemulsifying systems to enhance dissolution rate of poorly water soluble drugs. Pharm Dev Technol, 2012;17:277-84.
17. Pollex EK, Anger G, Hutson J, Koren G, Piquette-Miller M. Breast cancer resistance protein (BCRP)-mediated glyburide transport: Effect of the C421A/Q141K BCRP single-nucleotide polymorphism. Drug Metab Dispos, 2010;38:740-4.
18. Rao SV, Shao J. Self-nanoemulsifying drug delivery systems (SNEDDS) for oral delivery of protein drugs: I. Formulation development. Int J Pharm, 2008;362:2-9.
19. Schinkel AH, Jonker JW. Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: An overview. Adv Drug Deliv Rev, 2003;55:3-29.
20. Singh B, Singh R, Bandyopadhyay S, Kapil R, Garg B. Optimized nanoemulsifying systems with enhanced bioavailability of carvedilol. Colloids Surf B Biointerfaces, 2013;101:465-74.
21. Singh SK, Singare DS, Gowthamarajan K, Prakash D. Formulation of ternary complexes of glyburide with hydroxypropyl-b-cyclodextrin and other solubilizing agents and their effect on release behavior of glyburide in aqueous and buffered media at different agitation speeds. Drug Dev Ind Pharm, 2012b;38:1328-36.
22. Singh SK, Srinivasan KK, Gowthamarajan K, Prakash D, Gaikwad NB, Singare DS. Influence of formulation parameters on dissolution rate enhancement of glyburide using liquisolid technique. Drug Dev Ind Pharm, 2012a;38:961-70.
23. Singh SK, Srinivasan KK, Gowthamarajan K, Singare DS, Prakash D, Gaikwad NB. Investigation of preparation parameters of nanosuspension by top-down media milling to improve the dissolution of poorly water-soluble glyburide. Eur J Pharm Biopharm, 2011;78: 441-6.
24. Tang B, Cheng G, Gu JC, Xu CH. Development of solid self-emulsifying drug delivery systems: Preparation techniques and dosage forms. Drug Discov Today, 2008;13:606-12.
25. Valleri M, Mura P, Maestrelli F, Cirri M, Ballerini R. Development and evaluation of glyburide fast dissolving tablets using solid dispersion technique. Drug Dev Ind Pharm, 2004;30:525-34.
26. Yamagata T, Kusuhara H, Morishita M, Takayama K, Benameur H, Sugiyama Y. Effect of excipients on breast cancer resistance protein substrate uptake activity. J Control Rel, 2007;124:1-5.
27. Zerrouk N, Corti G, Ancillotti S, Maestrelli F, Cirri M, Mura P. Influence of cyclodextrins and chitosan, separately or in combination, on glyburide solubility and permeability. Eur J Pharm Biopharm, 2006; 62:241-6.